Grants and Contributions:

Back to search

Title:

Feasibility study: expanding vaccination training capacity

Agreement Number:

948110

Agreement Value:

$49,920.00

Agreement Date:

Apr 1, 2020 - Jun 15, 2020

Description:

Delivering COVID vaccine to 70% of the Canadian population will be 2 to 4 times the largest vaccination project in Canada history. This will result in delays in the public getting timely access to COVID vaccinations, and avoidable physician/ER visits, hospitalizations and deaths. This project addresses such delays before they start by transforming an injection license course that's 95% online to 100% by developing custom kit that enables safe and remote assessment of injections via a network camera The purpose of this project is to develop a low-cost network device (quite likely based on a low-cost Raspberry Pi 4) that can be shipped to participants so that they can complete an examination. Upon completion we will have a network camera that can support:

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

North York, Ontario, CA M3B 3S6

Reference Number:

172-2020-2021-Q1-948110

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

830583316

Recipient Type:

For-profit organization

Recipient's Legal Name:

PharmAchieve Corporation. Ltd.

Federal Riding Name:

Don Valley East

Federal Riding Number:

35019

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

6117